Skip to main content
FinSpry Logo
FinSpry
IPSC logo
IPSC
(NASDAQ)
Century Therapeutics, Inc.
$2.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Century Therapeutics (IPSC) Stock Price & Financial Analysis

Century Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.05 - $2.24
52-Week High$3.04
52-Week Low$0.34
Open$2.16
Volume678.39K
Average Volume (3M)678.39K
Market Cap184.37M
Shares Outstanding86.56M
Price to Sales (P/S)1.74
Price to Book (P/B)1.19
EV/EBITDA-175.86
Revenue (TTM)109.16M
Net Income (TTM)-9.58M
Free Cash Flow (TTM)-105.18M
EPS (TTM)$-0.11
Profit Margin-8.78%
Operating Margin-16.39%
Return on Equity (ROE)-6.03%
Debt to Equity0.25
50-Day MA$2.20
200-Day MA$1.05
52-Week Change384.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Century Therapeutics

What is the current stock price for IPSC?

As of the latest trading session, IPSC stock trades at $2.13. The 52-week range is $0.34–$3.04, with a day range of $2.05–$2.23.

What is the P/E ratio for IPSC?

The P/E ratio (Price-to-Earnings) for IPSC is shown in the Key Statistics section. This valuation metric helps compare Century Therapeutics, Inc. to industry peers.

Does IPSC pay dividends?

Century Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IPSC?

Based on 1 analyst, the consensus for IPSC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IPSC?

Century Therapeutics's market capitalization is $184.4M, classifying it as a micro-cap company. Century Therapeutics operates in the Healthcare sector within the Biotechnology industry.